Here are five notes:
1. The cash tender offer is to purchase all Derma Sciences’ outstanding common and preferred shares.
2. Integra will purchase the shares at an offer price of $7 per share for the common stock; $32 per share for Derma Sciences’ Series A Convertible Preferred Stock; and $48 per share for Derma Sciences’ Series B Convertible Preferred Stock.
3. The tender offer is set to expire at midnight, Eastern Time, on Feb. 22, 2017.
4. The tender offer includes no financing condition.
5. The companies announced an agreement and plan to merge on Jan. 10, 2017.
More articles on devices:
Johnson & Johnson CEO Alex Gorsky: 5 things to know on 2017
DePuy Synthes, Pacira partner on Exparel education: 5 key notes
Stryker expects 5.5% to 6.5% organic growth in 2017: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
